These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6134622)

  • 41. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T
    Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
    Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Oxmetidine--a new H2-receptor antagonist].
    Gugler R
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1809-11. PubMed ID: 6641532
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure.
    Sorensen EV; Faergeman O; Day M; Bastain W
    Eur J Clin Pharmacol; 1988; 35(2):183-5. PubMed ID: 2903827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of proxyphylline in adults after intravenous and oral administration.
    Selvig K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):149-55. PubMed ID: 7202475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
    Faulkner JK; McGibney D; Chasseaud LF; Perry JL; Taylor IW
    Br J Clin Pharmacol; 1986 Jul; 22(1):21-5. PubMed ID: 2943308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ranitidine bioavailability and kinetics in normal male subjects.
    Garg DC; Weidler DJ; Eshelman FN
    Clin Pharmacol Ther; 1983 Apr; 33(4):445-52. PubMed ID: 6299642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.
    Mills JG; Brunet PL; Griffiths R; Hunt RH; Vincent D; Milton-Thompson GJ; Burland WL
    Gut; 1982 Feb; 23(2):157-63. PubMed ID: 6121744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of ketanserin in man.
    Reimann IW; Okonkwo PO; Klotz U
    Eur J Clin Pharmacol; 1983; 25(1):73-6. PubMed ID: 6617728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers.
    Grind M; Nilsson MI; Nilsson L; Oxenstierna G; Sedvall G; Wahlén A
    Psychopharmacology (Berl); 1989; 98(3):304-9. PubMed ID: 2568653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolism of etintidine in rat, dog, and human.
    Wong FA; Lloyd JR; Graden DW
    Drug Metab Dispos; 1990; 18(6):949-53. PubMed ID: 1981542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose.
    Jönsson KA; Eriksson SE; Kagevi I; Norlander B; Bodemar G; Walan A
    Br J Clin Pharmacol; 1982 Dec; 14(6):815-9. PubMed ID: 7150460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
    Rawlins MD; Henderson DB; Hijab AR
    Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.
    Breithaupt B; Tittel M
    Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.